EPCAM and neoplasm: In human primary TNBC tissues, the reactivity of EpCAM(VU1D9) in tumor cells which have lost E‐cadherin or have undergone EMT was significantly lower than that in tumor cells which show E‐cadherin expression (Fig. 6B).